Felipe Gaia de Sousa

Dr. Felipe Gaia de Sousa

Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil
orcid
Departament of Veterinary Clinic and Surgery, Veterinary Sch...

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Felipe Gaia de SousaFelipe Gaia de Sousa
Felipe Gaia de Sousa
RFRosely Maria Luzia Fraga
Rosely Maria Luzia Fraga
AMAna Cristina Ribeiro Mendes
Ana Cristina Ribeiro Mendes
RSRogério Carvalho Souza
Rogério Carvalho Souza
SBSuzane Beier
Suzane Beier
Foodborne diseases (FBDs) represent significant public health concerns as they are conditions associated with deficient manufacturing practices. They comprise important diseases with acute or chronic courses, frequently occurring in outbreak form and associated with significant gastrointestinal disorders. FBDs are related to infrastructure and organizational issues in urban centers, such that contamination in food processing facilities, lack of access to basic sanitation, and social and financial vulnerability are some of the factors that favor their occurrence and the demand for health services. Among the agents associated with FBDs is Listeria sp., especially Listeria monocytogenes (L. monocytogenes). The objective of this article is to characterize L. monocytogenes and its potential impact on One Health, given its importance as a significant foodborne pathogen. A thorough scientific literature search was conducted to obtain information on the subject, aiming to assist in the verification and presentation of evidence. L. monocytogenes is a pathogen with specific characteristics that ensure its adhesion, adaptation, growth, and survival on various surfaces, such as biofilm formation ability and thermotolerance. Several diagnostic methods are available for detection of the agent, including enrichment media, molecular techniques, and subtyping evaluation. Its control represents a significant challenge, with critical implications due to bacterial perpetuation characteristics and the implementation/monitoring of sanitization programs and commercialization of animal-derived products (POAO). Thus, vulnerable and susceptible populations are more exposed to foodborne pathogens due to health-related determinants, such as inadequate sanitation, poor food safety control, and insufficient personal hygiene. The pathogen’s persistence and difficulty of control represent a significant public One Health threat.

23 May 2024 in Ticks and Tick-borne Diseases
Verified
Journal Article
Open access
LALeandro Silva Andrade
Leandro Silva Andrade
RSRayanne Soalheiro de Souza
Rayanne Soalheiro de Souza
AAAndreina Carvalho de Araujo
Andreina Carvalho de Araujo
SSSoraia de Oliveira Silva
Soraia de Oliveira Silva
MMMaria Norma Melo
Maria Norma Melo
JSJúlia Angélica Gonçalves da Silveira
Júlia Angélica Gonçalves da Silveira
The transplacental transmission of parasites and hemoparasites is crucial for understanding the epidemiology of diseases. This study aimed to assess the prevalence of hemopathogens in bovine fetuses at various gestational periods. Samples were obtained from a slaughterhouse in the state of Minas Gerais, Brazil, and a total of 236 fetuses were collected. DNA extracted from blood samples (145) and organ samples (a pool of brain and spleen) (236) underwent a nested PCR (nPCR) assay to detect Babesia spp., Theileria spp., Trypanosoma vivax, Anaplasma marginale, Anaplasma bovis, Anaplasma phagocytophilum, Ehrlichia minasensis, and hemotropic Mycoplasma spp. Additionally, serological analysis of 145 plasma samples was conducted using the indirect fluorescent antibody test-IFAT to detect IgG against Babesia bovis, Babesia bigemina, A. marginale, and Trypanosoma vivax. The observed prevalence of transplacental transmission was 19.3 %, 6.2 %, 42.7 % and 2.7 %, for A. marginale, B. bigemina, 'Candidatus M. haemobos', and Mycoplasma wenyonii, respectively. The prevalence of A. marginale by gestational trimester was 16 % (13/81) in the second trimester and 23 % (14/60) in the third trimester, with no positive samples in the first trimester. Regarding the species B. bovis and B. bigemina, all evaluated animals tested negative by nPCR, and no serological evidence for B. bovis was found by the IFAT. Babesia bigemina demonstrated an overall seroprevalence of 6.2 % (9/145), with 4.8 % (7/145) in the last trimester and 1.3 % (2/145) in the second trimester of pregnancy. In total, 42.7 % (62/145) of blood samples were positive for 'Candidatus M. haemobos', with 42 % (34/81) in the middle trimester, and 43 % (26/60) in the final trimester of pregnancy. Mycoplasma wenyonni was detected in 2.7 % (4/145) blood samples, all in coinfection with 'C. M. haemobos'. The prevalence by pregnancy trimester was 25 % (1/4) in the first trimester; 1.2 % (1/81) in the second trimester and 3.3 % (2/60) in the third trimester of pregnancy. Hemopathogen DNA was detected in fetus blood samples but not the brain or spleen samples. All the samples were negative for T. vivax, Theileria spp., Anaplasma spp. and Ehrlichia spp. Overall, in this study, approximately 70 % of fetuses were positive for one or more of the studied parasites. No significant associations were observed between pairs of pathogens, except 'C. M. haemobos' and A. marginale.

19 March 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
Felipe Gaia de SousaFelipe Gaia de Sousa
Felipe Gaia de Sousa
AMAna Cristina Ribeiro Mendes
Ana Cristina Ribeiro Mendes
LCLuisa Pimenta de Carvalho
Luisa Pimenta de Carvalho
SBSuzane Beier
Suzane Beier
A comprehensive literature review was conducted to summarise existing evidence and the latest therapeutic advancements in feline HCM. The disease phenotype is characterised by the development of concentric hypertrophy, which is variable but often asymmetric, primarily affecting the left ventricle. The HCM is marked by diastolic dysfunction, resulting in a reduced intracavitary internal diameter due to the disordered alignment of cardiomyocytes and excessive collagen deposition, which thickens the myocardial tissue and impairs relaxation. There is strong evidence supporting the role of genetic mutations in sarcomeric genes in the development of HCM. Clinical signs vary but are frequently associated with congestive heart failure (CHF) and ATE. Diagnosis is based on a combination of clinical evaluation, laboratory tests, and imaging studies, although certain aspects of the disease remain insufficiently understood and require further research. Therapeutic management focuses on controlling clinical signs, slowing disease progression, and improving both quality of life and life expectancy. However, ongoing studies are essential to refine diagnostic strategies and explore novel treatment options for better disease management.

9 May 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
Felipe Gaia de SousaFelipe Gaia de Sousa
Felipe Gaia de Sousa
FQFabiana Silva Fádel Queiroz
Fabiana Silva Fádel Queiroz
Ruthnea Aparecida Lazaro MuzziRuthnea Aparecida Lazaro Muzzi
Ruthnea Aparecida Lazaro Muzzi
JVJúlio César Cambraia Veado
Júlio César Cambraia Veado
SBSuzane Beier
Suzane Beier
Systemic arterial hypertension (SAH), characterised by a persistent increase in BP beyond the reference values for the species, is a concerning and detrimental clinical condition. The aim of this manuscript is to present the state of the art on SAH in companion animals, including the different types of hypertension, diagnostic and therapeutic approaches, and the factors associated with its occurrence, such as the role of stress. It also discusses the benefits and challenges related to the measurement process. SAH is categorised into types based on the underlying cause: situational, secondary, and idiopathic (the least frequently observed). The situational type occurs when stress is the primary factor, such as during veterinary visits, contact with other animals, or in cases of ‘white coat syndrome’. If the stressor is removed, BP values tend to normalise. The most common type of SAH is the secondary form, which is associated with an underlying condition, such as renal, cardiac, endocrine, or neurological diseases, or a combination of these. Diagnosing SAH is a challenging task for many veterinarians due to factors related to handling the animal, managing the equipment, and interpreting the results. Consequently, many professionals either take inaccurate measurements or misinterpret the results, often prescribing antihypertensive medications prematurely or unnecessarily. Despite being a well-standardised and well-documented process, challenges persist. Treatment often involves antihypertensive drugs, either alone or in combination, alongside management of the underlying causes, when present. Therefore, BP values should be obtained correctly, with clinical-therapeutic decisions carefully aligned with the factors that may influence them.

21 November 2023 in Veterinária e Zootecnia
Verified
Journal Article
Open access
PDF file
Felipe Gaia de SousaFelipe Gaia de Sousa
Felipe Gaia de Sousa
BOBárbara Oliveira
Bárbara Oliveira
NFNatália Ferreira
Natália Ferreira
MBMaria Luiza Baldi
Maria Luiza Baldi
FQFabiana Queiroz
Fabiana Queiroz
SBSuzane Beier
Suzane Beier
Doenças cardiovasculares representam condições clínicas que estão relacionadas com qualidade de vida e bem-estar, e a preocupação com tais doenças torna-se tarefa necessária, de modo a retardar o aparecimento, controlar a sintomatologia e/ou evitar a progressão. Diversas doenças de natureza cardiovascular são capazes de promover alterações clínicas variáveis, regionais e/ou sistêmicas, a depender da gravidade e progressão. Dentre essas doenças, a hipertensão arterial sistêmica merece destaque devido à possibilidade de repercussão hemodinâmica, de forma a interferir de modo deletério na qualidade de vida do paciente. A hipertensão arterial sistêmica (HAS) é caracterizada pelo incremento nos valores pressóricos de forma persistente em comparação com o intervalo de referência para a espécie, com possibilidade de repercussão orgânica. A HAS pode ser ainda classificada em três tipos, em hipertensão situacional, HAS primária e secundária, sendo o primeiro apenas momentâneo e principalmente estresse mediado. Os sinais clínicos associados à hipertensão sistêmica são derivados principalmente de condições de base. O diagnóstico é baseado na mensuração consecutiva dos valores de pressão por meio de manguitos específicos e em concordância com a circunferência do membro a ser avaliado. Ressalta-se que falsos diagnósticos de HAS prejudicam a percepção da condição e a busca de estratégias de tratamento efetivas. O tratamento de HAS baseia-se na redução dos valores de pressão, no controle de possíveis sinais associados, bem como no decréscimo no impacto em órgãos e sistemas. O presente artigo tem por objetivo descrever e caracterizar a hipertensão arterial sistêmica e as condutas para identificação, avaliação, controle e manejo terapêutico para cães e gatos.

5 September 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
TMTábata Torres Megda
Tábata Torres Megda
Felipe Gaia de SousaFelipe Gaia de Sousa
Felipe Gaia de Sousa
FMFernanda Guimarães Miranda
Fernanda Guimarães Miranda
MBMaira Souza Oliveira Barreto
Maira Souza Oliveira Barreto
CMCláudio Roberto Scabelo Mattoso
Cláudio Roberto Scabelo Mattoso
SBSuzane Beier
Suzane Beier
This prospective cohort study aimed to evaluate by echocardiogram the cardiovascular effects of α2 agents associated with butorphanol in cats. A group of 18 mixed-breed cats with a mean weight of 3.65 + 0.7 kg, with an approximate age of 6 months. The cats were assigned in three groups, XB (Xylazine/butorphanol group) sedation with 0.5 mg/kg of xylazine and 0.5 mg/kg of butorphanol IM; DB (Dexmedetomidine/butorphanol group): sedation with 20 µg/kg of dexmedetomidine and 0.5 mg/kg of butorphanol IM; C: control group which received saline solution in volume approximated to those used in the other groups, IM. Echocardiographic variables as ejection fraction (Simpson's method and M-mode) and left ventricular shortening fraction (M-mode), ejection volume, end-systolic volume and cardiac output (Teichholz), tissue Doppler E' and A' wave velocities and cardiac index were evaluated. There was a reduction in echocardiographic variables compared with the control group, being statistically significant for heart rate, ejection fraction (% by Simpson), shortening fraction (% in M-mode) and end-systolic volume in XB and DB groups, and tissue Doppler E' and A' wave velocity (m/s), E'/A' ratio, cardiac output and cardiac index only in XB group. When compared to each other, XB and DB differed significantly in the tissue Doppler E' and A' wave velocity (m/s), and E'/A' ratio. Xylazine was more deleterious than dexmedetomidine in most of the variables evaluated, leading to a significant reduction in cardiac output and cardiac index at the doses used in this study.